Chief Corporate Development Officer@ Anagram Therapeutics, Inc.
Framingham, Massachusetts, United States
Hugh Wight
GET FULL PROFILE 
Real-Time AI Research
FlashIntel GPT
Tell me more about Hugh Wight?
FlashIntel GPTHugh Wight is a highly experienced Pharmaceutical Manufacturing/Quality Executive with over 28 years of experience in various product classes and functional areas. He has a global and strategic mindset, having worked in corporate, regional, and site roles both locally and internationally. Hugh is skilled in FDA, validation, biotechnology, technology transfer, and GMP. He is focused on working within execution-minded companies seeking to develop and commercialize new products that meet patient needs. His specialties include Pharmaceutical Quality Assurance, Project Management, and Manufacturing.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Pharmaceutical Manufacturing/Quality Executive with over 28 years of accumulated experience in a broad range of product classes and functional areas. A global and strategic mindset acquired through hands on experience in corporate, regional and site roles, both locally and internationally. Career marked by advancement earned through a history of teamwork, collaboration, and demonstrated work ethic and achievement. Focused on working within execution-minded companies seeking to develop and commercialize new products that will serve unmet patient needs. Specialties: Pharmaceutical Quality Assurance. Project Management. Manufacturing.
...See MoreWork Experience
Chief Corporate Development Officer
Hugh Wight's Professional Milestones
- Senior Director, Quality Assurance (2010-02-01~2012-04-01): Implementing robust quality control measures, resulting in improved product performance and continuous improvement projects.
- Senior Vice President Technical Operations (2019-03-01~): Successfully streamlined technical operations, optimizing efficiency and enhancing overall productivity across the organization.
Skill
Fda
Validation
Biotechnology
Technology Transfer
Gmp
Change Control
Biopharmaceuticals
Pharmaceutical Industry
Capa
21 Cfr Part 11
Quality System
Sop
V&v
Regulatory Submissions
Glp
Regulatory Affairs
Cmc
Certification
Colleagues
John Ledoux
biotech finance & accounting manager
Alexey Margolin
Director
Pamela Nelson
Executive Vice President Regulatory Affairs
Geraldine Riera
Senior Director
Marcie Williams Clarkin
Vice President Clinical Strategic Operations
Other Named Hugh Wight
Frequently asked questions
We found 1 Hugh Wight's email addresses
We found 9 Hugh Wight's phone numbers
Hugh Wight works for Anagram Therapeutics, Inc.
Hugh Wight's role in Anagram Therapeutics, Inc. is Chief Corporate Development Officer
Hugh Wight's colleagues are John Ledoux,Alexey Margolin,Pamela Nelson
Hugh Wight's latest job experience is Chief Corporate Development Officer at Anagram Therapeutics, Inc.
